- Home
- Publications
- Publication Search
- Publication Details
Title
Role of the IL-23/IL-17 Pathway in Rheumatic Diseases: An Overview
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-02-22
DOI
10.3389/fimmu.2021.637829
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Response to: ‘Correspondence on ‘Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial’’ by Wang et al
- (2021) Renaud Felten et al. ANNALS OF THE RHEUMATIC DISEASES
- Dual neutralisation of interleukin-17A and interleukin-17F with bimekizumab in patients with active ankylosing spondylitis: results from a 48-week phase IIb, randomised, double-blind, placebo-controlled, dose-ranging study
- (2020) Désirée van der Heijde et al. ANNALS OF THE RHEUMATIC DISEASES
- A novel treatment for psoriatic arthritis
- (2020) Miao Chen et al. CHINESE MEDICAL JOURNAL
- Guselkumab in biologic-naive patients with active psoriatic arthritis (DISCOVER-2): a double-blind, randomised, placebo-controlled phase 3 trial
- (2020) Philip J Mease et al. LANCET
- Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNFα inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled phase 3 trial
- (2020) Atul Deodhar et al. LANCET
- Treatment of Axial Spondyloarthritis: What Does the Future Hold?
- (2020) Denis Poddubnyy et al. Current Rheumatology Reports
- The Role of the IL-23/IL-17 Pathway in the Pathogenesis of Spondyloarthritis
- (2020) Hiroyuki Tsukazaki et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Efficacy and safety of bimekizumab as add-on therapy for rheumatoid arthritis in patients with inadequate response to certolizumab pegol: a proof-of-concept study
- (2019) Sophie Glatt et al. ANNALS OF THE RHEUMATIC DISEASES
- Evidence that tissue resident human enthesis γδT-cells can produce IL-17A independently of IL-23R transcript expression
- (2019) Richard James Cuthbert et al. ANNALS OF THE RHEUMATIC DISEASES
- A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naïve patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial
- (2019) Philip J Mease et al. ANNALS OF THE RHEUMATIC DISEASES
- Critical role of interleukin (IL)-17 in inflammatory and immune disorders: An updated review of the evidence focusing in controversies
- (2019) José María G. Ruiz de Morales et al. AUTOIMMUNITY REVIEWS
- Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis (SELECT-AXIS 1): a multicentre, randomised, double-blind, placebo-controlled, phase 2/3 trial
- (2019) Désirée van der Heijde et al. LANCET
- Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial
- (2019) Atul Deodhar et al. LANCET
- Short-term and low-dose IL-2 therapy restores the Th17/Treg balance in the peripheral blood of patients with primary Sjögren’s syndrome
- (2018) Miao Miao et al. ANNALS OF THE RHEUMATIC DISEASES
- Role of the IL-23/IL-17 Axis in Psoriasis and Psoriatic Arthritis: The Clinical Importance of Its Divergence in Skin and Joints
- (2018) Marie-Astrid Boutet et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Hydroxychloroquine Inhibits the Differentiation of Th17 Cells in Systemic Lupus Erythematosus
- (2018) Ji Yang et al. JOURNAL OF RHEUMATOLOGY
- The pathogenesis of psoriatic arthritis
- (2018) Douglas J Veale et al. LANCET
- The rationale for Janus kinase inhibitors for the treatment of spondyloarthritis
- (2018) Douglas J Veale et al. RHEUMATOLOGY
- ABT-122, a Bispecific DVD-Immunoglobulin Targeting TNF- and IL-17A, in RA With Inadequate Response to Methotrexate: A Randomized, Double-Blind Study
- (2018) Mark C. Genovese et al. Arthritis & Rheumatology
- Phase 2 Study of ABT-122, a TNF- and IL-17A-Targeted Dual Variable Domain Immunoglobulin, in Psoriatic Arthritis With Inadequate Methotrexate Response
- (2018) Philip J. Mease et al. Arthritis & Rheumatology
- The Initiation, but Not the Persistence, of Experimental Spondyloarthritis Is Dependent on Interleukin-23 Signaling
- (2018) Melissa N. van Tok et al. Frontiers in Immunology
- Increased IL-22- and IL-17A-Producing Mucosal-Associated Invariant T Cells in the Peripheral Blood of Patients With Ankylosing Spondylitis
- (2018) Éric Toussirot et al. Frontiers in Immunology
- Ustekinumab in psoriatic arthritis and related phenotypes
- (2018) Isobel Dobbin-Sears et al. Therapeutic Advances in Chronic Disease
- Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study
- (2018) Dominique Baeten et al. ANNALS OF THE RHEUMATIC DISEASES
- The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis
- (2018) Andrew Blauvelt et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Efficacy and safety of ustekinumab, an IL-12 and IL-23 inhibitor, in patients with active systemic lupus erythematosus: results of a multicentre, double-blind, phase 2, randomised, controlled study
- (2018) Ronald F van Vollenhoven et al. LANCET
- IL-2 Inhibition of Th17 Generation Rather Than Induction of Treg Cells Is Impaired in Primary Sjögren’s Syndrome Patients
- (2018) Jing Luo et al. Frontiers in Immunology
- Anti-IL-17 monoclonal antibodies for the treatment of ankylosing spondylitis
- (2018) Daniel Wendling et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Efficacy and Safety of Ixekizumab in Patients with Active Psoriatic Arthritis: 52-week Results from a Phase III Study (SPIRIT-P1)
- (2018) JOURNAL OF RHEUMATOLOGY
- Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active ankylosing spondylitis (TORTUGA): results from a randomised, placebo-controlled, phase 2 trial
- (2018) Désirée van der Heijde et al. LANCET
- The Early Phases of Ankylosing Spondylitis: Emerging Insights From Clinical and Basic Science
- (2018) Abdulla Watad et al. Frontiers in Immunology
- Serum Interleukin-23 in Polish Patients with Systemic Lupus Erythematosus: Association with Lupus Nephritis, Obesity, and Peripheral Vascular Disease
- (2017) Katarzyna Fischer et al. MEDIATORS OF INFLAMMATION
- Role of HLA-B27 in the pathogenesis of ankylosing spondylitis
- (2017) Bin Chen et al. Molecular Medicine Reports
- Secukinumab sustains improvement in signs and symptoms of psoriatic arthritis: 2 year results from the phase 3 FUTURE 2 study
- (2017) Iain B McInnes et al. RHEUMATOLOGY
- Secukinumab and Sustained Improvement in Signs and Symptoms of Patients With Active Ankylosing Spondylitis Through Two Years: Results From a Phase III Study
- (2017) H. Marzo-Ortega et al. ARTHRITIS CARE & RESEARCH
- Safety, Tolerability, and Pharmacodynamics of ABT-122, a Tumor Necrosis Factor- and Interleukin-17-Targeted Dual Variable Domain Immunoglobulin, in Patients With Rheumatoid Arthritis
- (2017) Roy M. Fleischmann et al. Arthritis & Rheumatology
- Increased Interleukin-17F is Associated with Elevated Autoantibody Levels and More Clinically Relevant Than Interleukin-17A in Primary Sjögren’s Syndrome
- (2017) Yuzhou Gan et al. Journal of Immunology Research
- Analysis of Th17-associated cytokines and clinical correlations in patients with dry eye disease
- (2017) Rongjun Liu et al. PLoS One
- Involvement of Mucosal-associated Invariant T cells in Ankylosing Spondylitis
- (2016) E. Hayashi et al. JOURNAL OF RHEUMATOLOGY
- Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci
- (2016) David Ellinghaus et al. NATURE GENETICS
- Ankylosing Spondylitis and Axial Spondyloarthritis
- (2016) Joel D. Taurog et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sexual dimorphic function of IL-17 in salivary gland dysfunction of the C57BL/6.NOD-Aec1Aec2 model of Sjögren’s syndrome
- (2016) Alexandria Voigt et al. Scientific Reports
- Interleukin-9 Overexpression and Th9 Polarization Characterize the Inflamed Gut, the Synovial Tissue, and the Peripheral Blood of Patients With Psoriatic Arthritis
- (2016) Francesco Ciccia et al. Arthritis & Rheumatology
- The Role of IL-17 and TH17 Cells in the Bone Catabolic Activity of PTH
- (2016) Roberto Pacifici Frontiers in Immunology
- Type 3 innate lymphoid cells producing IL-17 and IL-22 are expanded in the gut, in the peripheral blood, synovial fluid and bone marrow of patients with ankylosing spondylitis
- (2015) Francesco Ciccia et al. ANNALS OF THE RHEUMATIC DISEASES
- Dry Eye Signs and Symptoms Persist During Systemic Neutralization of IL-1β by Canakinumab or IL-17A by Secukinumab
- (2015) Cynthia L. Grosskreutz et al. CORNEA
- The role and modulation of CCR6+ Th17 cell populations in rheumatoid arthritis
- (2015) Sandra M.J. Paulissen et al. CYTOKINE
- Th17 Cell Pathway in Human Immunity: Lessons from Genetics and Therapeutic Interventions
- (2015) Dhavalkumar D. Patel et al. IMMUNITY
- IL-17–Mediated Immunity to the Opportunistic Fungal PathogenCandida albicans
- (2015) Heather R. Conti et al. JOURNAL OF IMMUNOLOGY
- TH17 cells promote microbial killing and innate immune sensing of DNA via interleukin 26
- (2015) Stephan Meller et al. NATURE IMMUNOLOGY
- IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases
- (2015) Michele W L Teng et al. NATURE MEDICINE
- Genetics of ankylosing spondylitis—insights into pathogenesis
- (2015) Matthew A. Brown et al. Nature Reviews Rheumatology
- The IL-23–IL-17 axis in inflammatory arthritis
- (2015) Erik Lubberts Nature Reviews Rheumatology
- Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis
- (2015) Dominique Baeten et al. NEW ENGLAND JOURNAL OF MEDICINE
- CCR6+ Th cell populations distinguish ACPA positive from ACPA negative rheumatoid arthritis
- (2015) Sandra M. J. Paulissen et al. ARTHRITIS RESEARCH & THERAPY
- Major histocompatibility complex associations of ankylosing spondylitis are complex and involve further epistasis with ERAP1
- (2015) Adrian Cortes et al. Nature Communications
- Brief Report: Intestinal Dysbiosis in Ankylosing Spondylitis
- (2015) Mary-Ellen Costello et al. Arthritis & Rheumatology
- Th17 cells play a critical role in the development of experimental Sjögren's syndrome
- (2014) Xiang Lin et al. ANNALS OF THE RHEUMATIC DISEASES
- Ustekinumab for the treatment of patients with active ankylosing spondylitis: results of a 28-week, prospective, open-label, proof-of-concept study (TOPAS)
- (2014) Denis Poddubnyy et al. ANNALS OF THE RHEUMATIC DISEASES
- Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor
- (2014) Arthur Kavanaugh et al. ANNALS OF THE RHEUMATIC DISEASES
- Immunology of Psoriasis
- (2014) Michelle A. Lowes et al. Annual Review of Immunology
- Th17 cells in inflammation and autoimmunity
- (2014) Ram Pyare Singh et al. AUTOIMMUNITY REVIEWS
- The Role of Interleukin-17A in Psoriatic Disease
- (2014) Silvano Adami et al. BIODRUGS
- Cutting Edge: NKT Cells Constitutively Express IL-23 Receptor and ROR t and Rapidly Produce IL-17 upon Receptor Ligation in an IL-6-Independent Fashion
- (2014) A. V. Rachitskaya et al. JOURNAL OF IMMUNOLOGY
- Expanded Double Negative T Cells in Patients with Systemic Lupus Erythematosus Produce IL-17 and Infiltrate the Kidneys
- (2014) J. C. Crispin et al. JOURNAL OF IMMUNOLOGY
- Composition of Innate Lymphoid Cell Subsets in the Human Skin: Enrichment of NCR + ILC3 in Lesional Skin and Blood of Psoriasis Patients
- (2014) Marcel B.M. Teunissen et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- One-year Efficacy and Safety Results of Secukinumab in Patients With Rheumatoid Arthritis: Phase II, Dose-finding, Double-blind, Randomized, Placebo-controlled Study
- (2014) M. C. Genovese et al. JOURNAL OF RHEUMATOLOGY
- Crossreactive Autoantibodies Directed against Cutaneous and Joint Antigens Are Present in Psoriatic Arthritis
- (2014) Marzia Dolcino et al. PLoS One
- Rituximab modulates IL-17 expression in the salivary glands of patients with primary Sjögren’s syndrome
- (2014) Francesco Ciccia et al. RHEUMATOLOGY
- Heterogeneous expression pattern of interleukin 17A (IL-17A), IL-17F and their receptors in synovium of rheumatoid arthritis, psoriatic arthritis and osteoarthritis: possible explanation for nonresponse to anti-IL-17 therapy?
- (2014) Lisa GM van Baarsen et al. ARTHRITIS RESEARCH & THERAPY
- T lymphocyte subset imbalances in patients contribute to ankylosing spondylitis
- (2014) CHENGGONG WANG et al. Experimental and Therapeutic Medicine
- A Phase II Randomized Study of Subcutaneous Ixekizumab, an Anti-Interleukin-17 Monoclonal Antibody, in Rheumatoid Arthritis Patients Who Were Naive to Biologic Agents or Had an Inadequate Response to Tumor Necrosis Factor Inhibitors
- (2014) Mark C. Genovese et al. Arthritis & Rheumatology
- Endoplasmic Reticulum Degradation-Enhancing α-Mannosidase-like Protein 1 Targets Misfolded HLA-B27 Dimers for Endoplasmic Reticulum-Associated Degradation
- (2014) David B. Guiliano et al. Arthritis & Rheumatology
- Degree of bone marrow oedema in sacroiliac joints of patients with axial spondyloarthritis is linked to gut inflammation and male sex: results from the GIANT cohort
- (2013) Liesbet Van Praet et al. ANNALS OF THE RHEUMATIC DISEASES
- IL-17 family: Cytokines, receptors and signaling
- (2013) Chunfang Gu et al. CYTOKINE
- Interleukin-17-Induced Protein Lipocalin 2 Is Dispensable for Immunity to Oral Candidiasis
- (2013) Maria Carolina Ferreira et al. INFECTION AND IMMUNITY
- Synovial Fibroblasts Directly Induce Th17 Pathogenicity via the Cyclooxygenase/Prostaglandin E2 Pathway, Independent of IL-23
- (2013) S. M. J. Paulissen et al. JOURNAL OF IMMUNOLOGY
- Characterization of Innate Lymphoid Cells in Human Skin and Blood Demonstrates Increase of NKp44+ ILC3 in Psoriasis
- (2013) Federica Villanova et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial
- (2013) Dominique Baeten et al. LANCET
- HLA-B27 misfolding and ankylosing spondylitis
- (2013) Robert A. Colbert et al. MOLECULAR IMMUNOLOGY
- Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci
- (2013) Adrian Cortes et al. NATURE GENETICS
- A phase Ib multiple ascending dose study evaluating safety, pharmacokinetics, and early clinical response of brodalumab, a human anti-IL-17R antibody, in methotrexate-resistant rheumatoid arthritis
- (2013) David A Martin et al. ARTHRITIS RESEARCH & THERAPY
- Th17 and Th22 cells in psoriatic arthritis and psoriasis
- (2013) Helen Benham et al. ARTHRITIS RESEARCH & THERAPY
- Clinical associations of serum interleukin-17 in systemic lupus erythematosus
- (2013) Fabien B Vincent et al. ARTHRITIS RESEARCH & THERAPY
- IL-17-producing CD4−CD8−T cells are expanded in the peripheral blood, infiltrate salivary glands and are resistant to corticosteroids in patients with primary Sjögren's syndrome
- (2012) Alessia Alunno et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding, double-blind, randomised, placebo controlled study
- (2012) Mark C Genovese et al. ANNALS OF THE RHEUMATIC DISEASES
- Microscopic gut inflammation in axial spondyloarthritis: a multiparametric predictive model
- (2012) Liesbet Van Praet et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in ankylosing spondylitis
- (2012) Ejaz Pathan et al. ANNALS OF THE RHEUMATIC DISEASES
- The potential role of Th17 cells and Th17-related cytokines in the pathogenesis of lupus nephritis
- (2012) D-Y Chen et al. LUPUS
- Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β
- (2012) Christina E. Zielinski et al. NATURE
- IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4−CD8− entheseal resident T cells
- (2012) Jonathan P Sherlock et al. NATURE MEDICINE
- Interleukin-17-positive mast cells contribute to synovial inflammation in spondylarthritis
- (2011) Troy Noordenbos et al. ARTHRITIS AND RHEUMATISM
- Enrichment of circulating interleukin-17-secreting interleukin-23 receptor-positive γ/δ T cells in patients with active ankylosing spondylitis
- (2011) Tony J. Kenna et al. ARTHRITIS AND RHEUMATISM
- Pivotal Role of Dermal IL-17-Producing γδ T Cells in Skin Inflammation
- (2011) Yihua Cai et al. IMMUNITY
- Interleukin-23: as a drug target for autoimmune inflammatory diseases
- (2011) Chunlei Tang et al. IMMUNOLOGY
- IL-22 Is Required for Imiquimod-Induced Psoriasiform Skin Inflammation in Mice
- (2011) A. B. Van Belle et al. JOURNAL OF IMMUNOLOGY
- Mast Cells and Neutrophils Release IL-17 through Extracellular Trap Formation in Psoriasis
- (2011) A. M. Lin et al. JOURNAL OF IMMUNOLOGY
- The IL23R R381Q Gene Variant Protects against Immune-Mediated Diseases by Impairing IL-23-Induced Th17 Effector Response in Humans
- (2011) Paola Di Meglio et al. PLoS One
- Th17 cells, but not Th1 cells, from patients with early rheumatoid arthritis are potent inducers of matrix metalloproteinases and proinflammatory cytokines upon synovial fibroblast interaction, including autocrine interleukin-17A production
- (2010) J. P. van Hamburg et al. ARTHRITIS AND RHEUMATISM
- LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double-blind, placebo-controlled, proof-of-concept study
- (2010) M. C. Genovese et al. ARTHRITIS AND RHEUMATISM
- Synovial fluid-derived T helper 17 cells correlate with inflammatory activity in arthritis, irrespectively of diagnosis
- (2010) Gaetano Zizzo et al. CLINICAL IMMUNOLOGY
- Increased serum IL-17 and IL-23 in the patient with ankylosing spondylitis
- (2010) Yang Mei et al. CLINICAL RHEUMATOLOGY
- Tumor-infiltrating IL-17-producing γδ T cells support the progression of tumor by promoting angiogenesis
- (2010) Daiko Wakita et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- γδ T Cells Enhance Autoimmunity by Restraining Regulatory T Cell Responses via an Interleukin-23-Dependent Mechanism
- (2010) Franziska Petermann et al. IMMUNITY
- Dendritic cell differentiation with prostaglandin E2results in selective attenuation of the extracellular signal-related kinase pathway and decreased interleukin-23 production
- (2010) Fumie Hayashi et al. IMMUNOLOGY
- IL-23 Receptor Regulates Unconventional IL-17–Producing T Cells That Control Bacterial Infections
- (2010) Lorena Riol-Blanco et al. JOURNAL OF IMMUNOLOGY
- Structural Basis for the Dual Recognition of IL-12 and IL-23 by Ustekinumab
- (2010) Jinquan Luo et al. JOURNAL OF MOLECULAR BIOLOGY
- Rheumatoid arthritis
- (2010) David L Scott et al. LANCET
- Pathogenetic mechanisms in the initiation and perpetuation of Sjögren's syndrome
- (2010) Michael Voulgarelis et al. Nature Reviews Rheumatology
- Proinflammatory T helper type 17 cells are effective B-cell helpers
- (2010) M. Mitsdoerffer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Review of ustekinumab, an interleukin-12 and interleukin-23 inhibitor used for the treatment of plaque psoriasis
- (2010) Mark Lebwohl et al. Therapeutics and Clinical Risk Management
- Systemic and Local Interleukin-17 and Linked Cytokines Associated with Sjögren’s Syndrome Immunopathogenesis
- (2009) Gikas E. Katsifis et al. AMERICAN JOURNAL OF PATHOLOGY
- The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection
- (2009) M Rudwaleit et al. ANNALS OF THE RHEUMATIC DISEASES
- Systemic levels of IL-23 are strongly associated with disease activity in rheumatoid arthritis but not spondyloarthritis
- (2009) L. Melis et al. ANNALS OF THE RHEUMATIC DISEASES
- HLA-B27 misfolding and the unfolded protein response augment interleukin-23 production and are associated with Th17 activation in transgenic rats
- (2009) Monica L. DeLay et al. ARTHRITIS AND RHEUMATISM
- Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis
- (2009) Francesco Ciccia et al. ARTHRITIS AND RHEUMATISM
- Th17 and natural Treg cell population dynamics in systemic lupus erythematosus
- (2009) Ji Yang et al. ARTHRITIS AND RHEUMATISM
- TGF-β is necessary for induction of IL-23R and Th17 differentiation by IL-6 and IL-23
- (2009) Noriko Morishima et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Interleukin-1 and IL-23 Induce Innate IL-17 Production from γδ T Cells, Amplifying Th17 Responses and Autoimmunity
- (2009) Caroline E. Sutton et al. IMMUNITY
- Reconciling id, ego, and superego within interleukin-23
- (2009) Cristina M. Tato et al. IMMUNOLOGICAL REVIEWS
- Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genes
- (2009) Lisa C. Zaba et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- IL-17 induces osteoclastogenesis from human monocytes alone in the absence of osteoblasts, which is potently inhibited by anti-TNF-α antibody: A novel mechanism of osteoclastogenesis by IL-17
- (2009) Toru Yago et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis
- (2009) Heather R. Conti et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Skin and Peripheral Lymph Node Invariant NKT Cells Are Mainly Retinoic Acid Receptor-Related Orphan Receptor t+ and Respond Preferentially under Inflammatory Conditions
- (2009) J.-M. Doisne et al. JOURNAL OF IMMUNOLOGY
- IL-23 Is Required for Protection against Systemic Infection with Listeria monocytogenes
- (2009) K. D. Meeks et al. JOURNAL OF IMMUNOLOGY
- Cutting Edge: IL-23 Receptor GFP Reporter Mice Reveal Distinct Populations of IL-17-Producing Cells
- (2009) Amit Awasthi et al. JOURNAL OF IMMUNOLOGY
- The IL-23/Th17 Axis in the Immunopathogenesis of Psoriasis
- (2009) Antonella Di Cesare et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Synergism between tumor necrosis factor alpha and interleukin-17 to induce IL-23 p19 expression in fibroblast-like synoviocytes
- (2009) Michael Goldberg et al. MOLECULAR IMMUNOLOGY
- The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17–producing effector T helper cells in vivo
- (2009) Mandy J McGeachy et al. NATURE IMMUNOLOGY
- IL-9 induces differentiation of TH17 cells and enhances function of FoxP3+ natural regulatory T cells
- (2009) W. Elyaman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Abundant expression of the interleukin (IL)23 subunit p19, but low levels of bioactive IL23 in the rheumatoid synovium: differential expression and Toll-like receptor-(TLR) dependent regulation of the IL23 subunits, p19 and p40, in rheumatoid arthritis
- (2008) F Brentano et al. ANNALS OF THE RHEUMATIC DISEASES
- Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjögren's syndrome: Findings in humans and mice
- (2008) Cuong Q. Nguyen et al. ARTHRITIS AND RHEUMATISM
- Association of interleukin-23 receptor variants with ankylosing spondylitis
- (2008) Proton Rahman et al. ARTHRITIS AND RHEUMATISM
- Increased numbers of circulating polyfunctional Th17 memory cells in patients with seronegative spondylarthritides
- (2008) Camilla Jandus et al. ARTHRITIS AND RHEUMATISM
- Prostaglandin E2 synergistically with interleukin-23 favors human Th17 expansion
- (2008) C. Chizzolini et al. BLOOD
- Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: Implications for Th17-mediated inflammation in auto-immunity
- (2008) Chun Kwok Wong et al. CLINICAL IMMUNOLOGY
- γδ T cells: an important source of IL-17
- (2008) Christina L Roark et al. CURRENT OPINION IN IMMUNOLOGY
- T Helper 17 Lineage Differentiation Is Programmed by Orphan Nuclear Receptors RORα and RORγ
- (2008) Xuexian O. Yang et al. IMMUNITY
- Induction of lymphotoxin-α by interleukin-12 p40 homodimer, the so-called biologically inactive molecule, but not IL-12 p70
- (2008) Malabendu Jana et al. IMMUNOLOGY
- Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens
- (2008) Meredith M. Curtis et al. IMMUNOLOGY
- Possible Pathogenic Role of Th17 Cells for Atopic Dermatitis
- (2008) Chizuko Koga et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Psoriasis Is Characterized by Accumulation of Immunostimulatory and Th1/Th17 Cell-Polarizing Myeloid Dendritic Cells
- (2008) Lisa C. Zaba et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Guidelines of care for the management of psoriasis and psoriatic arthritis
- (2008) Alice Gottlieb et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- The differentiation of human TH-17 cells requires transforming growth factor-β and induction of the nuclear receptor RORγt
- (2008) Nicolas Manel et al. NATURE IMMUNOLOGY
- IRF4 is essential for IL-21-mediated induction, amplification, and stabilization of the Th17 phenotype
- (2008) M. Huber et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- IL-17 attenuates the anti-apoptotic effects of GM-CSF in human neutrophils
- (2007) Stéphane Dragon et al. MOLECULAR IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search